A subset of tumours of this class is known to acquire a characteristic pattern of substitution mutations including kataegis and the presence of signature 3 was strongly associated with BRCA1 and BRCA2 mutations within breast and pancreatic cancer types11, 12. The gene discussed is BRCA2; the disease is pancreatic neoplasm.